This app offers evidence-based guidance for healthcare professionals and interested individuals on safely discontinuing psychiatric medications. It covers antidepressants, benzodiazepines, gabapentinoids, and Z-drugs, providing principles, tapering regimens, and troubleshooting for withdrawal symptoms. The free version includes sample content, with full access available via in-app purchase.
5.8.6
November 25, 2025
$48.99
Maudsley Deprescribing Guide
Guidelines to stop Antidepressants
The Maudsley Deprescribing Guide provides evidence-based recommendations for safely discontinuing psychiatric medications like antidepressants, benzodiazepines, gabapentinoids, and Z-drugs. It aims to support healthcare professionals and patients in optimizing care and minimizing medication-related harm.
The guide specifically covers antidepressants, benzodiazepines, gabapentinoids, and Z-drugs. It offers detailed information on why, when, and how to deprescribe these commonly used medications.
It helps users distinguish between physical dependence and addiction, and differentiate withdrawal symptoms (like mood changes or insomnia) from symptoms of the underlying disorder that the medication was intended to treat.
Yes, it provides step-by-step guidance for safely stopping commonly used psychiatric medications. This includes fast, moderate, and slow tapering regimens tailored to individual needs.
The app offers a free download that includes sample content. Full access to all content requires an in-app purchase.
The Maudsley Deprescribing Guide is available for iPhone, iPad, and iPod. It is designed for users on the iOS platform.
The app was last updated on November 25, 2025, with version 5.8.6. This indicates a commitment to keeping the content current, though specific update frequency is not detailed.
Yes, the app contains advertisements. This is indicated by the 'hasAds' flag, meaning users may encounter ads while using the application.
